Bridged ring structures as pharmaceutical agents

Details for Australian Patent Application No. 2004282162 (hide)

Owner X-Ceptor Therapeutics, Inc.

Inventors Flatt, Brenton T.; Murphy, Brett; Martin, Richard; Mohan, Raju

Agent Davies Collison Cave

Pub. Number AU-B-2004282162

PCT Pub. Number WO2005/037755

Priority 60/511,457 14.10.03 US

Filing date 13 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 19 January 2012

International Classifications

C07C 37/20 (2006.01) Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring

C07C 39/16 (2006.01) Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring

C07C 39/21 (2006.01) Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring

C07C 39/367 (2006.01) Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring

C07C 43/23 (2006.01) Ethers

C07D 211/22 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/037755 Priority application(s): WO2005/037755

19 January 2012 Application Accepted

  Published as AU-B-2004282162

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004282164-Arylalkyland cycloalkylalkyl-piperazine derivatives and methods of their use

2004282161-Method for manufacturing a foam core having channel cuts